DXCM DexCom, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$85.36
· of 52w range
· above low
· to high
$54.1152w low
$92.5952w high
Market Cap (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Revenue (TTM)
$4.97B
your badges
52W Range
$54–$93
Analyst Rating
BUY
Price Target
$95
P/E
33.9
ROE
38.5%
Net Profit Margin
20.1%
Your badge strip is empty — pin a metric anywhere on this page.
DXCM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$85.36
Market Cap (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Revenue (TTM)
$4.97B
ROE (TTM)
38.5%
52W Range
$54–$93
DXCM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 13, 2022 | 4-for-1 | Forward |
About DexCom, Inc. - Common Stock Company overview from Wikipedia
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees11,000
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$4.66B2016-12-31 → 2025-12-31
EPS$2.092017-12-31 → 2025-12-31
Free Cash Flow$1.08B2016-12-31 → 2025-12-31
Net margin20.1%2018-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DXCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 33.95Y avg ≈114.7 | ≈114.7 | 28.0 | Fair value | |
| P/S (TTM) | 6.55Y avg ≈9.3 | ≈9.3 | 4.8 | Overvalued | |
| P/B (MRQ) | 12.35Y avg ≈14.6 | ≈14.6 | 4.7 | Overvalued | |
| Price / FCF (TTM) | 22.95Y avg ≈110.6 | ≈110.6 | · | · | |
| Price / Cash Flow (TTM) | 18.45Y avg ≈41.4 | ≈41.4 | 21.9 | Undervalued | |
| Price / Tangible Book (MRQ) | 12.85Y avg ≈15.9 | ≈15.9 | · | · | |
| PEG Ratio | ≈3.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | DXCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 62.5%5Y avg ≈63.4% | ≈63.4% | 64.0% | Weak | |
| Operating Margin (TTM) | 22.9%5Y avg ≈15.0% | ≈15.0% | 23.0% | In line | |
| EBITDA Margin (TTM) | 28.2%5Y avg ≈20.1% | ≈20.1% | 27.1% | In line | |
| Pretax Margin (TTM) | 25.8%5Y avg ≈16.2% | ≈16.2% | 21.6% | In line | |
| Net Profit Margin (TTM) | 20.1%5Y avg ≈13.0% | ≈13.0% | 15.3% | Top tier | |
| ROA (TTM) | 14.5%5Y avg ≈8.3% | ≈8.3% | 7.5% | Top tier | |
| ROE (TTM) | 38.5%5Y avg ≈21.9% | ≈21.9% | 14.1% | Top tier | |
| ROIC | 25.5%5Y avg ≈19.4% | ≈19.4% | 9.9% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DXCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.75Y avg ≈2.7 | ≈2.7 | 1.5 | In line | |
| Quick Ratio | 1.05Y avg ≈1.1 | ≈1.1 | 0.8 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | DXCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 15.6%5Y avg ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 3Y | 17.0%5Y avg ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | |
| EPS YoY | 47.2%5Y avg ≈21.9% | ≈21.9% | · | · | |
| Net Income YoY | 45.1%5Y avg ≈21.4% | ≈21.4% | · | · | |
| EPS CAGR 3Y | 36.6%5Y avg ≈24.9% | ≈24.9% | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | |
| Net Income CAGR 3Y | 34.8%5Y avg ≈24.3% | ≈24.3% | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | DXCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.75Y avg ≈0.6 | ≈0.6 | 0.5 | Top tier | |
| Inventory Turnover | 3.25Y avg ≈3.0 | ≈3.0 | 2.4 | Top tier | |
| Receivables Turnover | 4.25Y avg ≈4.5 | ≈4.5 | 6.1 | Weak | |
| Revenue / Employee | ≈$423.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
9.1%
Next Report
Oct 28, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 28, 2026 | $0.70 | $0.62 | 12.4% |
| March 31, 2026 | $0.56 | $0.48 | 17.0% | |
| Dec. 31, 2025 | $0.56 | $0.48 | 17.0% | |
| Sept. 30, 2025 | $0.61 | $0.58 | 5.3% | |
| June 30, 2025 | $0.48 | $0.45 | 6.8% | |
| March 31, 2025 | $0.32 | $0.33 | -4.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.14 | $5.38 | $5.37 | $5.52 | $23.21 | $19.01 | $9.64 | $7.37 | $4.82 | $3.35 | $2.71 | $1.81 | |
| Revenue / Share | $11.50 | $9.77 | $8.51 | $6.81 | $24.46 | $19.76 | $15.99 | · | · | · | · | · | |
| Cash Flow / Share | $3.55 | $2.40 | $1.76 | $1.57 | $4.42 | $4.88 | $3.41 | · | · | · | · | · | |
| Cash / Share | $2.38 | $1.55 | $1.47 | $1.66 | $10.85 | $8.51 | $4.87 | $12.63 | $5.07 | $1.12 | $1.05 | $0.93 | |
| EPS (TTM) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | · | 391,100,000 | 392,100,000 | 391,100,000 | · | 394,200,000 | 399,200,000 | 390,200,000 | · | 386,600,000 | 386,700,000 | 386,700,000 | · | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | · | 407,400,000 | 408,200,000 | 407,500,000 | · | 410,200,000 | 416,800,000 | 416,700,000 | · | 426,800,000 | 431,500,000 | 418,500,000 | · | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.95 | $7.66 | · | $6.99 | $6.56 | $5.78 | · | $5.07 | $6.08 | $5.67 | · | $5.87 | $5.44 | $5.76 | · | $4.72 | |
| Revenue / Share | $3.35 | $3.03 | · | $2.97 | $2.83 | $2.54 | · | $2.42 | $2.41 | $2.21 | · | $2.28 | $2.02 | $1.77 | · | $1.81 | |
| Cash Flow / Share | · | $1.34 | · | · | · | $0.45 | · | · | · | $0.50 | · | · | · | $0.37 | · | · | |
| Cash / Share | $2.93 | $2.90 | · | $4.71 | $2.96 | $2.31 | · | $1.59 | $2.34 | $2.15 | · | $1.67 | $3.09 | $1.61 | · | $1.81 | |
| EPS (TTM) | $2.52 | $2.33 | · | $1.79 | $1.43 | $1.33 | · | $1.66 | $1.61 | $1.54 | · | $0.92 | $0.87 | $0.71 | · | $0.16 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.97B | $4.82B | · | $4.52B | $4.30B | $4.15B | · | $3.95B | $3.93B | $3.80B | · | $3.40B | $3.20B | $3.02B | · | $2.79B | |
| Net Income TTM | $1000M | $930M | · | $721M | $572M | $535M | · | $681M | $667M | $639M | · | $377M | $358M | $292M | · | $244M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 26.7 | 27.0 | · | 37.6 | 61.0 | 51.3 | · | 40.4 | 70.4 | 90.1 | · | 101.4 | 147.7 | 163.6 | · | 503.4 | |
| P/S | 5.1 | 5.0 | · | 5.8 | 8.0 | 6.5 | · | 6.6 | 11.5 | 14.5 | · | 10.6 | 15.5 | 14.9 | · | 11.1 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| Earnings Yield | 3.7% | 3.7% | · | 2.7% | 1.6% | 1.9% | · | 2.5% | 1.4% | 1.1% | · | 0.99% | 0.68% | 0.61% | · | 0.20% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Gross Margin % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Operating Margin % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Net Income | $836M | $576M | $542M | $341M | $217M |
| Diluted EPS | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M |
Institutional owners (13F) 1,078 filers · $29.5B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
1,078
Value held
$29.5B
New positions
125
Exited positions
97
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 125 (-42 vs prior Q) | 97 (+5 vs prior Q) | 401 (+31 vs prior Q) | 365 (+14 vs prior Q) | +13.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3,257,066,468 | 49,074,378 | 11.03% | Shares |
| BlackRock, Inc. | $2,575,742,626 | 38,244,137 | 8.72% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,697,876,797 | 25,209,752 | 5.75% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,323,867,969 | 19,656,540 | 4.48% | Shares |
| STATE STREET CORP | $1,237,947,284 | 18,380,806 | 4.19% | Shares |
| Invesco Ltd. | $1,029,655,765 | 15,288,133 | 3.49% | Shares |
| BAILLIE GIFFORD & CO | $996,887,087 | 14,801,590 | 3.38% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $834,165,910 | 12,426,515 | 2.83% | Shares |
| ALLIANCEBERNSTEIN L.P. | $734,346,085 | 11,693,409 | 2.49% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $612,059,728 | 9,746,174 | 2.07% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $574,325,172 | 8,527,471 | 1.95% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462,914,937 | 6,873,273 | 1.57% | Shares |
| NORGES BANK | $462,565,862 | 6,868,090 | 1.57% | Shares |
| UBS Group AG | $408,530,217 | 6,065,779 | 1.38% | Shares |
| Amundi | $377,395,039 | 5,603,490 | 1.28% | Shares |
| MORGAN STANLEY | $347,275,842 | 5,156,282 | 1.18% | Shares |
| AMERIPRISE FINANCIAL INC | $324,681,713 | 4,820,775 | 1.10% | Shares |
| Castle Hook Partners LP | $260,667,534 | 3,870,342 | 0.88% | Shares |
| GOLDMAN SACHS GROUP INC | $253,142,816 | 3,758,616 | 0.86% | Shares |
| FRANKLIN RESOURCES INC | $242,183,395 | 3,595,893 | 0.82% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $240,915,152 | 3,560,621 | 0.82% | Shares |
| CIBC Bancorp USA Inc. | $232,974,509 | 3,454,735 | 0.79% | Shares |
| JPMORGAN CHASE & CO | $232,690,154 | 3,325,095 | 0.79% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231,627,696 | 3,439,164 | 0.78% | Shares |
| NORTHERN TRUST CORP | $221,927,948 | 3,295,144 | 0.75% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $218,060,428 | 3,237,720 | 0.74% | Shares |
| BANK OF AMERICA CORP /DE/ | $213,068,756 | 3,163,604 | 0.72% | Shares |
| RAYMOND JAMES FINANCIAL INC | $207,976,113 | 3,087,990 | 0.70% | Shares |
| AMERICAN CENTURY COMPANIES INC | $206,860,340 | 3,071,423 | 0.70% | Shares |
| CIBC Private Wealth Group LLC | $195,665,945 | 2,907,801 | 0.66% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $183,859,102 | 2,729,905 | 0.62% | Shares |
| Legal & General Group Plc | $173,237,203 | 2,572,193 | 0.59% | Shares |
| JANUS HENDERSON GROUP PLC | $166,077,317 | 2,644,539 | 0.56% | Shares |
| DEUTSCHE BANK AG\ | $164,034,901 | 2,435,559 | 0.56% | Shares |
| Bank of New York Mellon Corp | $155,554,805 | 2,309,648 | 0.53% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $152,790,681 | 2,268,607 | 0.52% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $149,327,006 | 2,217,179 | 0.51% | Shares |
| Employees Provident Fund Board | $147,498,453 | 2,190,029 | 0.50% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $142,152,983 | 2,109,812 | 0.48% | Shares |
| ROYAL BANK OF CANADA | $137,011,000 | 2,034,290 | 0.46% | Shares |
| FMR LLC | $127,510,091 | 1,893,246 | 0.43% | Shares |
| Nuveen, LLC | $123,266,328 | 1,830,235 | 0.42% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $117,263,085 | 1,741,100 | 0.40% | Put option |
| NOMURA HOLDINGS INC | $115,126,069 | 1,709,370 | 0.39% | Shares |
| AXA Investment Managers S.A. | $112,203,653 | 1,667,464 | 0.38% | Shares |
| BLAIR WILLIAM & CO/IL | $112,182,565 | 1,665,665 | 0.38% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $109,834,111 | 1,630,796 | 0.37% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $92,130,221 | 1,367,932 | 0.31% | Shares |
| DSM CAPITAL PARTNERS LLC | $91,537,742 | 1,359,135 | 0.31% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89,939,931 | 1,335,411 | 0.30% | Shares |
Company insiders 61 insiders · 37 officers · 26 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | Aug. 22, 2026 F | 418,908 | 2 | 0 | $1,001,761 |
| Andrew P Rasdal | President & CEO | May 2, 2006 M | 2,944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | March 22, 2017 S | 8,452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | May 15, 2007 A | 26,255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | Sept. 10, 2021 S | 19,280 | 0 | 0 | $0 |
| Sadie Stern | EVP Chief People & Culture Off | Sept. 28, 2026 S | 123,478 | 0 | 2 | $-447,644 |
| Michael Jon Brown | EVP Chief Legal Compliance Off | Sept. 15, 2026 S | 99,885 | 0 | 7 | $-873,358 |
| Jereme M Sylvain | EVP, Chief Financal Officer | Sept. 10, 2026 S | 146,828 | 0 | 1 | $-302,936 |
| Kevin R Sayer | Executive Chair | Aug. 20, 2026 S | 302,214 | 0 | 6 | $-8,303,410 |
| Jon Coleman | EVP, Chief Commercial Officer | June 4, 2026 S | 95,450 | 0 | 2 | $-722,628 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | Jan. 29, 2025 S | 42,044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | March 12, 2024 S | 66,641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | Dec. 18, 2023 D | 48,949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | Dec. 18, 2023 D | 58,469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | Nov. 24, 2023 S | 124,775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | Nov. 9, 2023 S | 47,725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | Sept. 11, 2023 D | 48,453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | March 10, 2023 D | 208,023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | March 10, 2023 D | 50,908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | May 9, 2022 S | 13,675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | March 9, 2022 D | 13,789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | Sept. 9, 2021 S | 16,254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | March 23, 2021 S | 6,654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | Sept. 9, 2020 D | 34,784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | March 11, 2020 S | 38,584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | July 16, 2018 S | 50,882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | March 9, 2017 M | 84,034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | Nov. 16, 2010 P | 3,387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | Aug. 16, 2010 A | · | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | March 12, 2010 A | · | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | March 12, 2010 A | · | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | March 12, 2010 A | 18,741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | May 19, 2008 A | · | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | March 24, 2008 A | 53,125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | Nov. 2, 2007 A | 10,967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | Aug. 2, 2007 A | · | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | March 9, 2007 A | · | 0 | 0 | $0 |
| Nicholas Augustinos | Director | Sept. 15, 2026 S | 29,293 | 0 | 2 | $-679,769 |
| Glenn S Boehnlein | Director | Sept. 10, 2026 A | 5,841 | 0 | 0 | $0 |
| Bridgette P Heller | Director | Aug. 12, 2026 S | 29,570 | 0 | 4 | $-277,672 |
| Mark G Foletta | Director | Aug. 3, 2026 S | 48,852 | 0 | 4 | $-627,183 |
| Albert Frederick Osterloh IV | Director | May 28, 2026 A | 8,691 | 0 | 0 | $0 |
| Euan A. Ashley | Director | May 28, 2026 A | 12,731 | 0 | 0 | $0 |
| Rimma Driscoll | Director | May 28, 2026 A | 17,319 | 0 | 0 | $0 |
| Kyle Malady | Director | May 28, 2026 A | 28,242 | 0 | 0 | $0 |
| Richard Alexander Collins | Director | May 28, 2026 A | 5,605 | 0 | 2 | $-389,410 |
| Renee D Gala | Director | May 28, 2026 A | 12,486 | 0 | 0 | $0 |
| Steven R Altman | Director | May 28, 2026 A | 5,565 | 0 | 0 | $0 |
| Karen M Dahut | Director | May 8, 2025 G | 17,779 | 0 | 0 | $0 |
| Eric Topol | Director | May 8, 2025 G | 380,545 | 0 | 0 | $0 |
| Barbara Kahn | Director | May 18, 2024 G | 22,575 | 0 | 0 | $0 |
| Jay S Skyler | Director | May 18, 2023 G | 63,348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Director | Sept. 1, 2016 S | 52,820 | 0 | 0 | $0 |
| Martin Doordan | Director | June 1, 2012 A | 39,633 | 0 | 0 | $0 |
| Donald A Lucas | Director | May 19, 2010 A | 16,448 | 0 | 0 | $0 |
| Donald L Lucas | Director | March 15, 2010 S | 69,076 | 0 | 0 | $0 |
| Sean Carney | Director | May 19, 2008 A | 20,285 | 0 | 0 | $0 |
| Glen D Nelson | Director | March 14, 2008 P | 170,654 | 0 | 0 | $0 |
| Kim D Blickenstaff | Director | May 23, 2007 A | 4,104 | 0 | 0 | $0 |
| Brenton Karl Ahrens | Director | April 13, 2006 A | 280,619 | 0 | 0 | $0 |
| Jorge A Valdes | · | March 13, 2017 S | 10,442 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 133 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IHI · iShares Trust | 4.91% | 1,844,741 SH | Sept. 11, 2026 | Daily |
| JMID · Janus Detroit Street Trust | 2.74% | 7,762 NS | July 31, 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 2.12% | 527 NS | July 31, 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 2.04% | 4,976 NS | July 31, 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1.96% | 948 NS | July 31, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.70% | 171,659 SH | Oct. 2, 2026 | Daily |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.58% | 373,925 SH | Oct. 2, 2026 | Daily |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1.28% | 17,329 NS | July 31, 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1.15% | 305,526 NS | July 31, 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 1.15% | 184,331 NS | July 31, 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1.01% | 5,118 NS | July 31, 2026 | N-PORT |
| IWP · iShares Trust | 0.95% | 2,162,676 SH | Sept. 11, 2026 | Daily |
| QFLR · Innovator ETFs Trust | 0.93% | 58,151 NS | July 31, 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0.81% | 20,420 NS | July 31, 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0.81% | 3,979 NS | July 31, 2026 | N-PORT |
| QNXT · iShares Trust | 0.62% | 2,014 SH | Sept. 11, 2026 | Daily |
| SDG · iShares Trust | 0.60% | 11,793 SH | Sept. 11, 2026 | Daily |
| VOT · VANGUARD INDEX FUNDS | 0.57% | 2,956,203 SH | Aug. 19, 2026 | Daily |
| PDP · Invesco Exchange-Traded Fund Trust | 0.57% | 97,454 SH | Oct. 2, 2026 | Daily |
| QIDX · Spinnaker ETF Series | 0.55% | 2,575 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.52% | 65,774 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 0.52% | 224,542 SH | Sept. 11, 2026 | Daily |
| COWZ · Pacer Funds Trust | 0.49% | 1,097,680 NS | July 31, 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.48% | 76,326 NS | July 31, 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0.48% | 1,038,926 SH | Oct. 2, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.46% | 183,141 NS | July 31, 2026 | N-PORT |
| IMCG · iShares Trust | 0.45% | 213,189 SH | Sept. 11, 2026 | Daily |
| IXJ · iShares Trust | 0.41% | 203,560 SH | Sept. 11, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.38% | 1,156,710 SH | Aug. 19, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.37% | 7,593 NS | July 31, 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0.34% | 23,742 SH | Aug. 19, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.27% | 187,634 NS | July 31, 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.25% | 8,362,213 SH | Aug. 19, 2026 | Daily |
| SIZE · iShares Trust | 0.24% | 12,297 SH | Sept. 11, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.24% | 16,587 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.24% | 1,572,597 SH | Sept. 11, 2026 | Daily |
| IMCB · iShares Trust | 0.23% | 45,160 SH | Sept. 11, 2026 | Daily |
| ESUM · Strategy Shares | 0.23% | 4,954 NS | July 31, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 2,329,076 SH | Oct. 2, 2026 | Daily |
| ESLG · Strategy Shares | 0.20% | 561 NS | July 31, 2026 | N-PORT |
| EUSA · iShares, Inc. | 0.19% | 43,412 SH | Sept. 11, 2026 | Daily |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0.18% | 181,851 NS | July 31, 2026 | N-PORT |
| XOEF · iShares Trust | 0.18% | 485 SH | Sept. 11, 2026 | Daily |
| LRND · New York Life Investments ETF Trust | 0.18% | 8,712 NS | July 31, 2026 | N-PORT |
| CATH · Global X Funds | 0.15% | 23,840 NS | July 31, 2026 | N-PORT |
| QYLG · Global X Funds | 0.15% | 2,837 NS | July 31, 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0.15% | 21,359 NS | July 31, 2026 | N-PORT |
| QTR · Global X Funds | 0.15% | 136 NS | July 31, 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.15% | 895 NS | July 31, 2026 | N-PORT |
| QYLD · Global X Funds | 0.15% | 141,287 NS | July 31, 2026 | N-PORT |
| QCLR · Global X Funds | 0.14% | 57 NS | July 31, 2026 | N-PORT |
| QRMI · Global X Funds | 0.14% | 246 NS | July 31, 2026 | N-PORT |
| QQQM · Invesco Exchange-Traded Fund Trust … | 0.14% | 1,735,537 SH | Oct. 2, 2026 | Daily |
| QQQ · Invesco QQQ Trust, Series 1 | 0.14% | 7,901,347 SH | Oct. 2, 2026 | Daily |
| QSIX · Pacer Funds Trust | 0.14% | 298 NS | July 31, 2026 | N-PORT |
| USXF · iShares Trust | 0.13% | 22,924 SH | Sept. 11, 2026 | Daily |
| QUAL · iShares Trust | 0.12% | 666,753 SH | Sept. 11, 2026 | Daily |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.11% | 20,921 NS | July 31, 2026 | N-PORT |
| GARP · iShares Trust | 0.11% | 40,229 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.11% | 7,089 NS | July 31, 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0.11% | 10,730 NS | July 31, 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.10% | 56,316 SH | Oct. 2, 2026 | Daily |
| ILCG · iShares Trust | 0.10% | 37,554 SH | Sept. 11, 2026 | Daily |
| AQLT · iShares Trust | 0.10% | 3,937 SH | Sept. 11, 2026 | Daily |
| IQSU · New York Life Investments ETF Trust | 0.10% | 3,878 NS | July 31, 2026 | N-PORT |
| IWF · iShares Trust | 0.10% | 1,441,625 SH | Sept. 11, 2026 | Daily |
| CHRI · Global X Funds | 0.10% | 93 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 8,945 SH | Oct. 2, 2026 | Daily |
| DSI · iShares Trust | 0.09% | 58,749 SH | Sept. 11, 2026 | Daily |
| VUG · VANGUARD INDEX FUNDS | 0.09% | 4,943,048 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.09% | 499,383 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.09% | 23,598 NS | July 31, 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 603,971 SH | Aug. 19, 2026 | Daily |
| WRND · New York Life Investments ETF Trust | 0.08% | 100 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.08% | 31,150 NS | July 31, 2026 | N-PORT |
| EGLE · Global X Funds | 0.08% | 20 NS | July 31, 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0.08% | 10 NS | July 31, 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.06% | 12,050 SH | Oct. 2, 2026 | Daily |
| TOPC · iShares Trust | 0.06% | 230 SH | Sept. 11, 2026 | Daily |
| XVV · iShares Trust | 0.06% | 4,446 SH | Sept. 11, 2026 | Daily |
| XRMI · Global X Funds | 0.06% | 333 NS | July 31, 2026 | N-PORT |
| XTR · Global X Funds | 0.06% | 32 NS | July 31, 2026 | N-PORT |
| XCLR · Global X Funds | 0.05% | 23 NS | July 31, 2026 | N-PORT |
| IVE · iShares Trust | 0.05% | 312,923 SH | Sept. 11, 2026 | Daily |
| XYLG · Global X Funds | 0.05% | 394 NS | July 31, 2026 | N-PORT |
| XYLD · Global X Funds | 0.05% | 19,868 NS | July 31, 2026 | N-PORT |
| IUSV · iShares Trust | 0.05% | 165,780 SH | Sept. 11, 2026 | Daily |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.05% | 66,881 SH | Oct. 2, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.05% | 2,246 SH | Oct. 2, 2026 | Daily |
| TOV · EA Series Trust | 0.05% | 1,441 NS | July 31, 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0.05% | 912 NS | July 31, 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.05% | 32,725 NS | July 31, 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.05% | 53,113 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.05% | 19,478 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.05% | 4,868,303 SH | Sept. 11, 2026 | Daily |
| DFVX · Dimensional ETF Trust | 0.05% | 3,126 NS | July 31, 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.05% | 6,516 NS | July 31, 2026 | N-PORT |
| ILCB · iShares Trust | 0.05% | 7,544 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.05% | 120,564 NS | July 31, 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.05% | 5,347 SH | Oct. 2, 2026 | Daily |
| VOXP · Advisors Series Trust | 0.05% | 33 NS | July 31, 2026 | N-PORT |
| IVW · iShares Trust | 0.05% | 421,263 SH | Sept. 11, 2026 | Daily |
| IYY · iShares Trust | 0.05% | 16,523 SH | Sept. 11, 2026 | Daily |
| IWB · iShares Trust | 0.05% | 264,795 SH | Sept. 11, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.05% | 1,456 NS | July 31, 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.05% | 9,285 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.05% | 67,183 NS | July 31, 2026 | N-PORT |
| IUSG · iShares Trust | 0.04% | 173,802 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.04% | 499,542 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.04% | 104,639 SH | Sept. 11, 2026 | Daily |
| PHDG · Invesco Actively Managed Exchange-T… | 0.04% | 297 SH | Oct. 2, 2026 | Daily |
| VOO · VANGUARD INDEX FUNDS | 0.04% | 10,024,256 SH | Aug. 19, 2026 | Daily |
| VV · VANGUARD INDEX FUNDS | 0.04% | 450,660 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.04% | 12,252,641 SH | Aug. 19, 2026 | Daily |
| VOOG · VANGUARD ADMIRAL FUNDS | 0.04% | 146,079 SH | Aug. 19, 2026 | Daily |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.04% | 43,354 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.04% | 63,234 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.04% | 32,310 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.04% | 86,728 SH | Aug. 19, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.04% | 2,682 NS | July 31, 2026 | N-PORT |
| TOK · iShares Trust | 0.04% | 1,068 SH | Sept. 11, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.04% | 30,165 NS | July 31, 2026 | N-PORT |
| URTH · iShares, Inc. | 0.04% | 34,971 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.03% | 8,908 NS | July 31, 2026 | N-PORT |
| ACWI · iShares Trust | 0.03% | 121,058 SH | Sept. 11, 2026 | Daily |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.03% | 29,507 SH | Oct. 2, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 28,890 SH | Oct. 2, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 323,858 SH | Aug. 19, 2026 | Daily |
| DYNF · BlackRock ETF Trust | 0.02% | 87,332 SH | Sept. 11, 2026 | Daily |
| USCL · iShares Trust | 0.02% | 5,063 SH | Sept. 11, 2026 | Daily |
| LGDX · Tidal Trust III | 0.01% | 229 NS | July 31, 2026 | N-PORT |
| CRBN · iShares Trust | 0.01% | 1,408 SH | Sept. 11, 2026 | Daily |
| PEVC · Pacer Funds Trust | 0.00% | 1 NS | July 31, 2026 | N-PORT |
DXCM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 36 analysts
BUY
Median target
$95.00
+11.3%
15 41.7%
Strong Buy
16 44.4%
Buy
5 13.9%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
25 analysts · 2026-10-02Mean target $95.08 +11.4%
Now
Current price $85.36
Low$79.00
Mean$95.08
High$115.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | · | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
BLUECHIP_DIP
Stopped out
risk 1
reward 1.92
entry
$64.82
R:R 1.92
BLUECHIP_DIP
Stopped out
risk 1
reward 1.85
entry
$65.02
R:R 1.85
RANGE
Stopped out
risk 1
reward 4.99
entry
$63.32
R:R 4.99
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026